Janus Henderson Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.1M | Buy |
|
|||||
|
2025
Q2 | $930K | Sell |
|
|||||
|
2025
Q1 | $7.27M | Buy |
|
|||||
|
2024
Q4 | $970K | Hold |
|
|||||
|
2024
Q3 | $813K | Hold |
|
|||||
|
2024
Q2 | $858K | Sell |
|
|||||
|
2024
Q1 | $991K | Buy |
|
|||||
|
2023
Q4 | $1.68M | Sell |
|
|||||
|
2023
Q3 | $1.12M | Buy |
|
|||||
|
2023
Q2 | $1.29M | Buy |
|
|||||
|
2023
Q1 | $1.01M | Buy |
|
|||||
|
2022
Q4 | $388K | Sell |
|
|||||
|
2022
Q3 | $796K | Buy |
|
|||||
|
2022
Q2 | $348K | Sell |
|
|||||
|
2022
Q1 | $55.6M | Buy |
|
|||||
|
2021
Q4 | $47.5M | Buy |
|
|||||
|
2021
Q3 | $32.4M | Buy |
|
|||||
|
2021
Q2 | $47.1M | Sell |
|
|||||
|
2021
Q1 | $139M | Buy |
|
|||||
|
2020
Q4 | $272M | Sell |
|
|||||
|
2020
Q3 | $235M | Buy |
|
|||||
|
2020
Q2 | $190M | Buy |
|
|||||
|
2020
Q1 | $62.9M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $3.74M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $50.8M | Sell |
|
|||||
|
2018
Q3 | $65.2M | Sell |
|
|||||
|
2018
Q2 | $52.7M | Sell |
|
|||||
|
2018
Q1 | $157M | Buy |
|
|||||
|
2017
Q4 | $204M | Buy |
|
|||||
|
2017
Q3 | $224M | Buy |
|
|||||
|
2017
Q2 | $102M | Buy |
|